Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia
AbstractT-cell acute lymphoblastic leukemia (T-ALL) is an aggressive disease caused by the malignant transformation of immature progenitors primed towards T-cell development. Clinically, T-ALL patients present with diffuse infiltration of the bone marrow by immature T-cell blasts high blood cell counts, mediastinal involvement, and diffusion to the central nervous system. In the past decade, the genomic landscape of T-ALL has been the target of intense research. The identification of specific genomic alterations has contributed to identify strong oncogenic drivers and signaling pathways regulating leukemia growth. Notwithstanding, T-ALL patients are still treated with high-dose multiagent chemotherapy, potentially exposing these patients to considerable acute and long-term side effects. This review summarizes recent advances in our understanding of the signaling pathways relevant for the pathogenesis of T-ALL and the opportunities offered for targeted therapy. View Full-Text
Share & Cite This Article
Bongiovanni, D.; Saccomani, V.; Piovan, E. Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia. Int. J. Mol. Sci. 2017, 18, 1904.
Bongiovanni D, Saccomani V, Piovan E. Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences. 2017; 18(9):1904.Chicago/Turabian Style
Bongiovanni, Deborah; Saccomani, Valentina; Piovan, Erich. 2017. "Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia." Int. J. Mol. Sci. 18, no. 9: 1904.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.